Healthcare provider profile · identity verified

Virender Hak, MD

Internal Medicine · JERICHO, NY · NPI 1558317537

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	39
Amlodipine Besylate	Amlodipine Besylate	246	27
Eliquis	Apixaban	180	20
Levothyroxine Sodium	Levothyroxine Sodium	178	15
Memantine Hcl	Memantine Hcl	174	18
Clopidogrel	Clopidogrel Bisulfate	163	15
Latanoprost	Latanoprost	161	17
Metoprolol Succinate	Metoprolol Succinate	146	14
Mirtazapine	Mirtazapine	138	11
Donepezil Hcl	Donepezil Hcl	137	18
Furosemide	Furosemide	136	14
Simvastatin	Simvastatin	122	13
Pantoprazole Sodium	Pantoprazole Sodium	119	26
Metformin Hcl	Metformin Hcl	114	13
Januvia	Sitagliptin Phosphate	112	suppressed
Lisinopril	Lisinopril	106	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	105	12
Gabapentin	Gabapentin	105	16
Losartan Potassium	Losartan Potassium	104	15
Valproic Acid	Valproic Acid	104	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	98	suppressed
Lactulose	Lactulose	97	13
Metoprolol Tartrate	Metoprolol Tartrate	95	11
Divalproex Sodium	Divalproex Sodium	89	suppressed
Carvedilol	Carvedilol	88	suppressed
Nifedipine Er	Nifedipine	88	12
Enalapril Maleate	Enalapril Maleate	83	suppressed
Famotidine	Famotidine	76	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	70	11
Tradjenta	Linagliptin	68	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	64	11
Sertraline Hcl	Sertraline Hcl	62	suppressed
Levetiracetam	Levetiracetam	60	suppressed
Entresto	Sacubitril/Valsartan	56	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	51	suppressed
Benztropine Mesylate	Benztropine Mesylate	50	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	47	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	46	suppressed
Risperidone	Risperidone	46	suppressed
Potassium Chloride	Potassium Chloride	45	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	39	suppressed
Hydrocortisone	Hydrocortisone	35	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	34	20
Midodrine Hcl	Midodrine Hcl	33	suppressed
Omeprazole	Omeprazole	32	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	29	suppressed
Nystatin	Nystatin	29	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Finasteride	Finasteride	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Tivicay	Dolutegravir Sodium	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Insulin Aspart Flexpen	Insulin Aspart	24	suppressed
Insulin Lispro	Insulin Lispro	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Prednisone	Prednisone	24	suppressed
Rhopressa	Netarsudil Mesylate	24	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	23	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Phenobarbital	Phenobarbital	22	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Gemtesa	Vibegron	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ssd	Silver Sulfadiazine	18	suppressed
Valsartan	Valsartan	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Atenolol	Atenolol	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Lumigan	Bimatoprost	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Haloperidol Lactate	Haloperidol Lactate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Nystop	Nystatin	15	suppressed
Santyl	Collagenase Clostridium Hist.	15	suppressed
Sevelamer Hcl	Sevelamer Hcl	15	suppressed
Trazodone Hcl	Trazodone Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Vyzulta	Latanoprostene Bunod	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Baclofen	Baclofen	12	suppressed
Ozempic	Semaglutide	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Hydroxyurea	Hydroxyurea	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error